Dr. Andre J. Witkin, M.D.
Retina Specialist (Retina Specialist (Ophthalmology) Physician)
- Medicare participating
At a glance
- Medical school
- Js Weill Medical College, Cornell University (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 1,128
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Medical school: Js Weill Medical College, Cornell University
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Retina Specialist (Ophthalmology) Physician primary
MA license 250825 · NH license 15686 -
Ophthalmology Physician
MA license 250825 · PA license MD439612
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Tufts Medical Center Boston, MA
- Massachusetts Eye and Ear Infirmary - Boston, MA
Medical groups
- Ophthalmic Consultants of Boston Inc (68 clinicians)
- Pratt Ophthalmology Associates Inc (53 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,128
- Services billed
- 14,275
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Injection, faricimab-svoa, 0.1 mg | 4,080 | 17 |
| Injection, aflibercept, 1 mg | 3,210 | 307 |
| Imaging of retina | 2,967 | 1,145 |
| Injection of drug into eye | 1,720 | 392 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,572 | 449 |
| Established patient complete exam of visual system | 974 | 703 |
| Established patient office or other outpatient visit, 30-39 minutes | 329 | 270 |
| Injection, bevacizumab, 10 mg | 152 | 46 |
| Established patient problem focused exam of visual system | 70 | 57 |
| Photography of the retina | 44 | 39 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisolone Acetate Other prescribers in Boston, MA | 110 |
| Latanoprost Other prescribers in Boston, MA | 65 |
| Ketorolac Tromethamine Other prescribers in Boston, MA | 59 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Boston, MA | 42 |
| Brimonidine Tartrate Other prescribers in Boston, MA | 30 |
| Timolol Maleate Other prescribers in Boston, MA | 18 |
| Erythromycin (erythromycin base) Other prescribers in Boston, MA | 13 |
| Prednisone Other prescribers in Boston, MA | 12 |
| Atropine Sulfate | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 11 payments worth $5,118 in total to this clinician.
| Genentech USA, Inc. | $2,925 |
|---|---|
| Bausch & Lomb Americas Inc. | $1,295 |
| Genentech, Inc. | $290 |
| Neurotech Pharmaceuticals, Inc. | $234 |
| Astellas Pharma US Inc | $156 |
| Alcon Vision LLC | $154 |
| AbbVie Inc. | $40.43 |
| Sight Sciences, Inc. | $23.74 |
| Consulting Fee | $4,200 |
|---|---|
| Food and Beverage | $918 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genentech USA, Inc. Apr 11, 2025 | Consulting Fee Susvimo · Immunology and Ophthalmology | $2,925 |
| Bausch & Lomb Americas Inc. May 9, 2025 | Consulting Fee enVista MX60 IOL · Ophthalmology | $1,275 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.